Related Experiment Video
Updated: Feb 10, 2026

Author Spotlight: Integrating Ultrasound Imaging with Biochemical Markers for Thyroid Disease Diagnosis
Published on: February 9, 2024
Rational Design of Cancer Nanomedicine: Nanoproperty Integration and Synchronization
Qihang Sun1, Zhuxian Zhou1, Nasha Qiu1
1Center for Bionanoengineering and Key Laboratory of Biomass Chemical Engineering of Ministry of Education, College of Chemical and Biological Engineering, Zhejiang University, Zheda Road 38, 310027, Hangzhou, China.
Abstract:
Current cancer nanomedicines can only mitigate adverse effects but fail to enhance therapeutic efficacies of anticancer drugs. Rational design of next-generation cancer nanomedicines should aim to enhance their therapeutic efficacies. Taking this into account, this review first analyzes the typical cancer-drug-delivery process of an intravenously administered nanomedicine and concludes that the delivery involves a five-step CAPIR cascade and that high efficiency at every step is critical to guarantee high overall therapeutic efficiency. Further analysis shows that the nanoproperties needed in each step for a nanomedicine to maximize its efficiency are different and even opposing in different steps, particularly what the authors call the PEG, surface-charge, size and stability dilemmas. To resolve those dilemmas in order to integrate all needed nanoproperties into one nanomedicine, stability, surface and size nanoproperty transitions (3S transitions for short) are proposed and the reported strategies to realize these transitions are comprehensively summarized. Examples of nanomedicines capable of the 3S transitions are discussed, as are future research directions to design high-performance cancer nanomedicines and their clinical translations.
Insights
Next-generation cancer nanomedicines need rational design to improve drug efficacy. This review introduces stability, surface, and size transitions (3S transitions) to overcome nanomedicine delivery challenges for enhanced cancer therapy.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Pharmacology
Background:
- Current cancer nanomedicines offer limited therapeutic benefits, primarily mitigating side effects rather than enhancing drug efficacy.
- Rational design is crucial for developing advanced nanomedicines that improve anticancer drug effectiveness.
Purpose of the Study:
- To analyze the cancer-drug-delivery process and identify critical steps for enhancing therapeutic efficiency.
- To address the conflicting nanoproperty requirements at different delivery stages, known as the PEG, surface-charge, size, and stability dilemmas.
- To propose and review strategies for achieving stability, surface, and size transitions (3S transitions) in nanomedicines.
Main Methods:
- Analysis of the five-step cancer-drug-delivery cascade (CAPIR cascade) for intravenously administered nanomedicines.
- Identification of opposing nanoproperty requirements at various stages of drug delivery.
- Comprehensive review of reported strategies to achieve 3S transitions.
Main Results:
- High efficiency at each step of the CAPIR cascade is essential for overall therapeutic success.
- Conflicting demands on nanomedicine properties (PEGylation, surface charge, size, stability) present significant design challenges.
- 3S transitions offer a viable approach to integrate necessary nanoproperties for improved performance.
Conclusions:
- Overcoming nanomedicine design dilemmas through 3S transitions is key to developing high-performance anticancer therapies.
- Further research and development are needed to translate these advanced nanomedicines into clinical practice.
- Future directions focus on designing nanomedicines with dynamic property-switching capabilities for enhanced cancer treatment.
Related Concept Videos
Rationalizing Substitutions
Integration of Rational Functions Using Partial Fractions
Rational Expressions
Asymptotes in Rational Functions
Rational Emotive Behavior Therapy
Group Design

